DESTIN, Fla. — All patients who are immunocompromised should be educated about how to recognize COVID-19 infection early and when to report to the emergency room, according to Leonard H. Calabrese, DO, at the Congress of Clinical Rheumatology East.
These patients also require access to home testing, as many of the available COVID-19 therapies, including antivirals and monoclonal antibodies, are “time limited” and will be ineffective if administered several weeks after infection, he added.
“We’re rheumatologists — this is the type of patient we take care of,”
VIDEO: Immunocompromised care in COVID-19 to challenge physicians ‘for rest of our lives’
DESTIN, Fla. — All patients who are immunocompromised should be educated about how to recognize COVID-19 infection early and when to report to the emergency room, according to Leonard H. Calabrese, DO, at the Congress of Clinical Rheumatology East.
These patients also require access to home testing, as many of the available COVID-19 therapies, including antivirals and monoclonal antibodies, are “time limited” and will be ineffective if administered several weeks after infection, he added.
“We’re rheumatologists — this is the type of patient we take care of,”